Status of global AI healthcare market

The market size of AI applications for healthcare was US$19.2 billion in 2023, and DIGITIMES Research estimates that the market will grow at a compound annual growth rate (CAGR) of 35.8% to reach US$159.7 billion in 2030. Taiwan's AI healthcare market was NT$360 million (US$11.32 million) in 2023 and is expected to grow at a CAGR of 17.3% to reach NT$1.12 billion in 2030.

Geographically, North America is the biggest market, accounting for nearly 50% of the global AI healthcare market, followed by Europe in second place, and the Asia-Pacific region in third. However, due to increases in population, healthcare costs and government investments in healthcare infrastructure, the Asia-Pacific region is the fastest growing region in the AI healthcare market.

What motivates a medical sector to leverage AI applications depends on the amount of data it has to handle, the prevalence and R&D efficiency. In terms of data volume, medical imaging accounts for the largest amount of medical data, so AI is most widely used in medical image analysis at present.

• Introduction

• Market scale

• Chart 1: Global and Taiwan AI healthcare market scale, 2023-2030 (US$b)

• Regions

• Table 1: Global AI healthcare market scale share by region, 2023

• Application fields

• Table 2: Major application fields and functions of AI healthcare

• Al/ML medical device

• US

• Chart 2: Number of AI/ML medical devices approved by US FDA and number by application department, 2020-2024 (cases)

• Taiwan

• Chart 3: Number of AI/ML medical devices approved by TFDA and number by application department, 2022-2023 (cases)

• Taiwan-based developers

• Table 3: AI/ML medical devices approved by TFDA, 2023

• Summary